½ÃÀ庸°í¼­
»óǰÄÚµå
1595510

±âµµ¾ç¾Ð ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Positive Airway Pressure Devices Market by Product Type, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

±âµµ¾ç¾Ð ±â±â ½ÃÀåÀº 2023³â¿¡ 19¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 20¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 7.19%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 31¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

PAP(Positive Airway Pressure) ÀåÄ¡´Â ÁÖ·Î ¼ö¸é¹«È£ÈíÁõ Ä¡·á¿¡ »ç¿ëµË´Ï´Ù. ÀÌ ¹üÀ§¿¡´Â Áö¼ÓÀû ±âµµ ¾ç¾Ð(CPAP), ÀÚµ¿ Á¶Àý ¾ç¾Ð(APAP) ¹× ÀÌÁß ¾ç¾Ð(BiPAP) ÀåÄ¡°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Àåºñ´Â ¼ö¸éÀÇ ÁúÀ» °³¼±ÇÏ°í ½ÉÀ庴 ¹× °íÇ÷¾Ð°ú °°Àº °ü·Ã °Ç°­ À§ÇèÀ» ÁÙÀÌ´Â µ¥ Áß¿äÇÑ ºñħ½ÀÀû ȯ±â Áö¿øÀ» Á¦°øÇϱ⠶§¹®¿¡ ÇʼöÀûÀ̸ç, PAP ÀåÄ¡ÀÇ ¿ëµµ´Â °¡Á¤»Ó¸¸ ¾Æ´Ï¶ó º´¿ø ¹× ¼ö¸é Ŭ¸®´ÐÀ¸·Î È®ÀåµÇ¾î ÃÖÁ¾ ¿ëµµÀÇ ¹üÀ§°¡ ³Ð¾îÁö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ¼ö¸é¹«È£ÈíÁõ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¼ÒÇü ¹× ÈÞ´ë¿ë ÀåÄ¡¿Í °°Àº ±â±â ¼³°èÀÇ ±â¼ú ¹ßÀü, À¯¸®ÇÑ º¸Çè Àû¿ë µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºñ¸¸°ú °í·ÉÈ­·Î ÀÎÇÑ »ýȰ½À°üº´ Áõ°¡µµ ½ÃÀå ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº ±â±â °¡°Ý, ȯÀÚÀÇ ºÒÆíÇÔÀ¸·Î ÀÎÇÑ ¼øÀÀµµ ÀúÇÏ, ±¸°­ ±â±â ¹× ¿Ü°úÀû °³ÀÔ°ú °°Àº ´ëü Ä¡·áÀÇ °¡¿ë¼º µîÀÇ ¹®Á¦µµ ¿©ÀüÈ÷ ³²¾Æ ÀÖ½À´Ï´Ù. ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ Á¦Á¶¾÷ü´Â ±â±âÀÇ ÆíÀǼºÀ» ³ôÀ̰í, µ¥ÀÌÅÍ ÃßÀû ¹× ¿ø°Ý ÀÇ·á Ç÷§Æû°úÀÇ ÅëÇÕÀ» À§ÇÑ ½º¸¶Æ® ±â¼úÀ» µµÀÔÇϰí, ÀÇ·á ÀÎÇÁ¶ó°¡ ¹ßÀüÇϰí ÀÖ´Â ½ÅÈï±¹ ½ÃÀå °³Ã´¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. Çõ½ÅÀº »ç¿ëÀÚ Ä£È­ÀûÀÎ µðÀÚÀΰú ¼ÒÀ½ °¨¼Ò, °¡½À°ú °°Àº ±â´É °­È­¿¡ ÃÊÁ¡À» ¸ÂÃß¾î¾ß ÇÕ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü ¹× º¸Çè»ç¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ½ÃÀå ħÅõ·ÂÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. °³ÀÎÈ­µÈ Ä¡·á ȯ°æÀ» À§ÇÑ º¸´Ù ÀûÀÀ·ÂÀÌ ³ôÀº ¾Ë°í¸®Áò¿¡ ´ëÇÑ ¿¬±¸´Â Çõ½ÅÀ» À§ÇÑ ºñ¿ÁÇÑ Åä¾çÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº ¿©ÀüÈ÷ Æ´»õ ½ÃÀåÀ̸ç, ÀÎÁö À庮À» ±Øº¹Çϰí ȯÀÚ ±³À° Ä·ÆäÀÎÀ» ÃËÁøÇÏ´Â °ÍÀÌ ¼ºÀåÀÇ ¿­¼èÀÔ´Ï´Ù. µû¶ó¼­ PAP ±â±â ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ºñÁî´Ï½º ¼ºÀåÀ» À§Çؼ­´Â R&D¿¡ ´ëÇÑ Àü·«Àû ÅõÀÚ¿Í °í°´ Áß½ÉÀÇ Á¦Ç° °³¹ßÀÌ ÇʼöÀûÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 19¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 20¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 31¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 7.19%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ±âµµ¾ç¾Ð ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

±âµµ¾ç¾Ð ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ö¸é¹«È£ÈíÁõÀ¸·Î ÀÎÇÑ ³ôÀº À¯º´·ü°ú °æÁ¦Àû ºÎ´ã
    • È£Èí±â Áúȯ ȯÀÚ Áõ°¡
    • ±âµµ ¾ç¾Ð ÀåÄ¡ Á¤ºÎ ½ÂÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Àåºñ¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦
  • ½ÃÀå ±âȸ
    • ±âµµ ¾ç¾Ð ÀåÄ¡ÀÇ ±â¼úÀû Áøº¸
    • Á¦Ç°ÀÇ ³ôÀº ¿Â¶óÀÎ °¡¿ë¼º
  • ½ÃÀå °úÁ¦
    • ÀåºñÀÇ ±â¼úÀû ÇѰè

Portre's Five Forces: ±âµµ¾ç¾Ð ±â±â ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Porter's Five ForcesÀº ±âµµ¾ç¾Ð ±â±â ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ±âµµ¾ç¾Ð ±â±â ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ±âµµ¾ç¾Ð ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ±âµµ¾ç¾Ð ±â±â ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

±âµµ¾ç¾Ð ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ±âµµ¾ç¾Ð ±â±â ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ±âµµ¾ç¾Ð ±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

±âµµ¾ç¾Ð ±â±â ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

±âµµ¾ç¾Ð ±â±â ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ±âµµ¾ç¾Ð ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°

  • Auto - Titrating Positive Airway Pressure
  • Bi -Level Positive Airway Pressure
  • Continuous Positive Airway Pressure

Á¦7Àå ±âµµ¾ç¾Ð ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • °¡Á¤Ä¡·á ȯ°æ
  • º´¿ø ¹× ¼ö¸é ¿¬±¸½Ç

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ±âµµ¾ç¾Ð ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±âµµ¾ç¾Ð ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±âµµ¾ç¾Ð ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • 3B Medical, Inc.
  • Apex Medical Corporation
  • Armstrong Medical Inc.
  • Becton, Dickinson and Company
  • BMC Medical Co., Ltd.
  • Breas Medical AB
  • Drive DeVilbiss Healthcare, Inc.
  • Dymedso Inc.
  • Fisher & Paykel Healthcare Limited
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • medin Medical Innovations GmbH
  • Microchip Technology Inc.
  • Narang Medical Limited
  • ResMed Corporation
  • Salter Labs Inc.
  • Teijin Pharma Limited
  • Texas Instruments Incorporated
LSH

The Positive Airway Pressure Devices Market was valued at USD 1.93 billion in 2023, expected to reach USD 2.06 billion in 2024, and is projected to grow at a CAGR of 7.19%, to USD 3.14 billion by 2030.

Positive Airway Pressure (PAP) Devices are primarily used in the treatment of sleep apnea, a disorder characterized by repeated breathing interruptions during sleep. The scope encompasses Continuous Positive Airway Pressure (CPAP), Auto-adjusting Positive Airway Pressure (APAP), and Bi-level Positive Airway Pressure (BiPAP) devices. These devices are essential as they provide non-invasive ventilation support, which is crucial for improving the quality of sleep and reducing associated health risks like heart disease and hypertension. The application of PAP devices extends beyond home settings to hospitals and sleep clinics, broadening their end-use scope. Key growth factors include rising awareness about sleep apnea, technological advancements in device design, such as compact and portable units, and favorable insurance coverage. Additionally, the increasing prevalence of lifestyle diseases due to obesity and aging populations boosts market demand. However, challenges persist, such as the high cost of devices, patient discomfort leading to low compliance, and the availability of alternative treatments like oral appliances and surgical interventions. To capitalize on potential opportunities, manufacturers should focus on increasing device comfort, incorporating smart technology for data tracking and integration with telemedicine platforms, and expanding market reach in developing regions with growing healthcare infrastructure. Innovation should target user-friendly designs and enhancing features like noise reduction and humidification. Strategic partnerships with healthcare providers and insurers can improve market penetration. Research into more adaptive algorithms for personalized therapy settings presents fertile ground for innovation. The market remains competitive but niche, with growth hinging on overcoming perception barriers and fostering patient education campaigns. Hence, strategic investments in R&D and customer-centric product development are imperative for sustained business growth in the PAP device market.

KEY MARKET STATISTICS
Base Year [2023] USD 1.93 billion
Estimated Year [2024] USD 2.06 billion
Forecast Year [2030] USD 3.14 billion
CAGR (%) 7.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Positive Airway Pressure Devices Market

The Positive Airway Pressure Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence and economic burden caused by sleep apnea
    • Rising cases of respiratory disorders
    • Government approvals of positive airway pressure devices
  • Market Restraints
    • Stringent regulations on device
  • Market Opportunities
    • Technological advancements in positive airway pressure devices
    • High online availability of products
  • Market Challenges
    • Technical limitations of the device

Porter's Five Forces: A Strategic Tool for Navigating the Positive Airway Pressure Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Positive Airway Pressure Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Positive Airway Pressure Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Positive Airway Pressure Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Positive Airway Pressure Devices Market

A detailed market share analysis in the Positive Airway Pressure Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Positive Airway Pressure Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Positive Airway Pressure Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Positive Airway Pressure Devices Market

A strategic analysis of the Positive Airway Pressure Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Positive Airway Pressure Devices Market, highlighting leading vendors and their innovative profiles. These include 3B Medical, Inc., Apex Medical Corporation, Armstrong Medical Inc., Becton, Dickinson and Company, BMC Medical Co., Ltd., Breas Medical AB, Drive DeVilbiss Healthcare, Inc., Dymedso Inc., Fisher & Paykel Healthcare Limited, Invacare Corporation, Koninklijke Philips N.V., medin Medical Innovations GmbH, Microchip Technology Inc., Narang Medical Limited, ResMed Corporation, Salter Labs Inc., Teijin Pharma Limited, and Texas Instruments Incorporated.

Market Segmentation & Coverage

This research report categorizes the Positive Airway Pressure Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Auto - Titrating Positive Airway Pressure, Bi -Level Positive Airway Pressure, and Continuous Positive Airway Pressure.
  • Based on End-User, market is studied across Home Care Settings and Hospitals & Sleep Labs.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence and economic burden caused by sleep apnea
      • 5.1.1.2. Rising cases of respiratory disorders
      • 5.1.1.3. Government approvals of positive airway pressure devices
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations on device
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in positive airway pressure devices
      • 5.1.3.2. High online availability of products
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of the device
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Positive Airway Pressure Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Auto - Titrating Positive Airway Pressure
  • 6.3. Bi -Level Positive Airway Pressure
  • 6.4. Continuous Positive Airway Pressure

7. Positive Airway Pressure Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Home Care Settings
  • 7.3. Hospitals & Sleep Labs

8. Americas Positive Airway Pressure Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Positive Airway Pressure Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Positive Airway Pressure Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3B Medical, Inc.
  • 2. Apex Medical Corporation
  • 3. Armstrong Medical Inc.
  • 4. Becton, Dickinson and Company
  • 5. BMC Medical Co., Ltd.
  • 6. Breas Medical AB
  • 7. Drive DeVilbiss Healthcare, Inc.
  • 8. Dymedso Inc.
  • 9. Fisher & Paykel Healthcare Limited
  • 10. Invacare Corporation
  • 11. Koninklijke Philips N.V.
  • 12. medin Medical Innovations GmbH
  • 13. Microchip Technology Inc.
  • 14. Narang Medical Limited
  • 15. ResMed Corporation
  • 16. Salter Labs Inc.
  • 17. Teijin Pharma Limited
  • 18. Texas Instruments Incorporated
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦